Table 1 Pooled risk ratio estimates for overall and disease-free survival by presence or absence of extranodal extension.

From: Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis

Parameter

N. of studies

No. of events in ENE+

No. of ENE+

No. of events in ENE−

No. of ENE−

Risk ratio (95% CI)

P-value

Heterogeneity

Egger’s bias test; p-value

Trim and fill [trimmed]

ACM

1

20

71

5

31

1.75 (0.72–4.23)

0.22

CSM

4

97

312

51

198

1.21 (0.98–1.50)

0.08

I2 = 0

0.87; 0.30

1.18 (0.94–1.50)1

ROR

3

248

477

163

321

1.15 (1.04–1.28)

0.008

I2 = 0

0.29; 0.87

Unchanged

  1. Abbreviations: ENE: extranodal extension; CI: confidence interval; ACM: all-cause mortality; CSM: cancer-specific mortality; ROR: risk of recurrence.
  2. Bold values are significant results with p-values < 0.05.